Indeed, both treatments with STING agonist and 2’3-cGAMP can induce CXCL10 production and block cell proliferation specifically in Notch2-mutated but not in Notch1-mutated or Notch-wt SCLC [74]. Here, CXCL10 is linked to small cell lung carcinoma.